A1c of 5.6

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Understanding the Implications of an A1C Level of 5.6%

A1C as a Diagnostic Tool for Diabetes Screening

Hemoglobin A1c (A1C) is a widely used marker for diagnosing diabetes and assessing the risk of developing the disease. Research indicates that an A1C level of 5.6% is significant in predicting future diabetes. In a study involving 10,038 participants, an A1C cutoff of 5.6% was found to have the highest combined sensitivity (59%) and specificity (77%) for predicting the onset of diabetes over six years. Men with an A1C of 5.6% had a 2.4-fold increased risk, while women had a 3.1-fold increased risk of developing diabetes .

Risk of Diabetes with A1C Levels Between 5.5% and 6.0%

A systematic review of multiple studies has shown that A1C levels between 5.5% and 6.0% are associated with a moderately increased risk of developing diabetes, with an incidence rate ranging from 9% to 25% over five years. This range indicates a significant risk, although it is lower than the risk associated with higher A1C levels .

Screening and Diagnosis in Clinical Practice

In clinical settings, an A1C level of 5.6% is often used to identify individuals at risk for diabetes. Studies have shown that many individuals with an A1C between 5.6% and 6.9% have abnormal glucose status, necessitating follow-up and potential intervention . This highlights the importance of using A1C as a screening tool in routine clinical practice.

Comparison with Other Diagnostic Methods

While A1C is a useful marker, it is not always the most sensitive method for detecting early diabetes or impaired glucose tolerance (IGT). Research comparing A1C with fasting plasma glucose (FPG) and 2-hour plasma glucose tests found that A1C levels between 5.7% and 6.4% detected fewer at-risk individuals compared to FPG and IGT, particularly among non-Hispanic whites . This suggests that a combination of A1C and plasma glucose determinations may be more effective for early diagnosis.

Heterogeneity in Predictive Value Across Populations

The predictive value of an A1C level of 5.6% can vary across different populations. Studies involving diverse cohorts, such as the Framingham Heart Study and the Multi-Ethnic Study on Atherosclerosis, have shown variability in the incidence rates of diabetes among individuals with prediabetic A1C levels. This variability underscores the need to consider ethnic and cohort-specific factors when using A1C for diabetes prediction .

Conclusion

An A1C level of 5.6% is a critical marker for identifying individuals at increased risk of developing diabetes. While it is a convenient and effective screening tool, its sensitivity can vary across different populations and may be less effective than other diagnostic methods in some cases. Therefore, a combination of A1C and plasma glucose tests is recommended for a more comprehensive assessment of diabetes risk.

Sources and full results

Most relevant research papers on this topic

Hemoglobin A1c as a Diagnostic Tool for Diabetes Screening and New-Onset Diabetes Prediction

A1C is an effective and convenient method for diabetes screening, with a cutoff of 5.9% identifying undiagnosed diabetes and individuals with A1C 5.6% having an increased risk for future diabetes.

Observational StudyRigorous JournalHighly Cited

2011·

95citations

·S. Choi et al.

A1C Level and Future Risk of Diabetes: A Systematic Review

A1C values between 5.5 and 6.5% are associated with a substantially increased risk for developing diabetes.

Systematic ReviewRigorous JournalHighly Cited

2010·

317citations

·Xuanping Zhang et al.

A1C for Screening and Diagnosis of Type 2 Diabetes in Routine Clinical Practice

A1C 5.5% and 7.0% effectively predict the absence or presence of type 2 diabetes, with 6.5-6.9% being highly probable in clinical and population settings.

Observational StudyRigorous JournalHighly Cited

2010·

88citations

·Zhong-Xia Lu et al.

A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors

A1C 5.7-6.4% is less sensitive for detecting at-risk individuals than impaired glucose tolerance and impaired fasting glucose, particularly among non-Hispanic whites.

Observational StudyRigorous JournalHighly Cited

2010·

172citations

·C. Lorenzo et al.

Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic states.

A1C is not sufficiently sensitive or reliable for diagnosing early diabetes or impaired glucose tolerance, and a combination of A1C and plasma glucose determinations is recommended for diagnosis or screening.

Observational Study

2011·

39citations

·S. Fajans et al.

196-LB: Heterogeneity in Elevated Glucose and A1C as Predictors of the Prediabetes-to-Diabetes Transition—Framingham Heart Study, Multiethnic Study on Atherosclerosis, Jackson Heart Study, and Atherosclerosis Risk In Communities

Heterogeneity in elevated glucose and A1C levels predicts the transition from prediabetes to diabetes, with no clear explanation from body mass index or ethnic differences.

Meta-Analysis

2023·

0citations

·C. Patel

Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes–2016. Diabetes Care 2016;39(Suppl. 1):S13–S22

An A1C range of 5.7–6.4% (39–47 mmol/mol) is reasonable for identifying individuals with prediabetes.

Very Rigorous JournalHighly Cited

2016·

110citations

First Trimester Hemoglobin A1c Prediction of Gestational Diabetes

A first trimester A1C of 5.7-6.40% is associated with a 13% sensitivity and 94% specificity for predicting gestational diabetes mellitus, making it a poor test for identifying women who will develop GDM.

Observational StudyRigorous Journal

2016·

52citations

·Sarah S. Osmundson et al.

A1C to Detect Diabetes in Healthy Adults

Rescreening at intervals shorter than 3 years is not optimal for healthy adults with A1C levels below 6.5%, as it identifies few individuals with an A1C 6.5%.

Observational StudyRigorous Journal

2010·

27citations

·O. Takahashi et al.

Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes

The strong relationship between A1C and fasting plasma glucose in moderate dysglycemia is not significantly affected by ethnic or geographic differences, but oral antidiabetes drugs alter this relationship.

Observational StudyVery Rigorous Journal

2012·

22citations

·Ambady Ramachandran et al.

Try another search

can you take gabapentin with tramadol

anxiety physical symptoms

supplements that lower blood sugar

light for seasonal affective disorder

bipolar i vs ii

is sertraline an ssri